From: YRNA expression predicts survival in bladder cancer patients
Expression median (range) | ROC analysis | Sensitivity | Specificity | Cut-off | |||
---|---|---|---|---|---|---|---|
BCA (n = 88) | CTRL (n = 30) | AUC | 95%CI | ||||
RNY1 | 0.15 (0.0–1.75) | 0.59 (0.02–2.54) | 0.851 | 0.760–0.941 | 73.3% | 90.9% | 0.471 |
RNY3 | 0.21 (0.0–1.96) | 0.84 (0.03–3.24) | 0.863 | 0.778–0.949 | 80.0% | 88.6% | 0.527 |
RNY4 | 0.61 (0.0–8.96) | 2.92 (0.05–18.41) | 0.844 | 0.755–0.933 | 86.7% | 75.0% | 1.061 |
RNY5 | 1.15 (0.0–8.41) | 2.34 (0.07–18.75) | 0.715 | 0.601–0.829 | 73.3% | 75.0% | 1.948 |